Breast Cancer Clinical Trial
Official title:
Reducing Barriers to Pain and Fatigue Management
RATIONALE: Collecting information over time about patients' and health care providers'
understanding of pain and fatigue and providing education about pain and fatigue management
may improve quality of life.
PURPOSE: This clinical trial is studying pain and fatigue management in patients with breast
cancer, prostate cancer, colon cancer, or lung cancer.
OBJECTIVES:
- To test the effects of the Passport to Comfort (Passport) intervention at 1 and 3
months post-intervention by comparing baseline data to the high-intensity intervention.
- To test the effects of select demographic and disease/treatment variables on outcomes
of the Passport model at 1 and 3 months post-intervention compared to pre-intervention.
- To examine perceived patient and professional satisfaction with the Passport model.
- To test the effects of the Passport intervention by comparing high-intensity to
low-intensity.
OUTLINE: Patients are stratified according to cancer diagnosis (breast vs prostate vs colon
vs lung), pain level (< 4 vs ≥ 4 on pain scale), and fatigue level (< 4 vs ≥ 4 on fatigue
scale). Patients are assigned to 1 of 3 groups.
- Group 1 (enrolled during months 1-8): Patients undergo pain and fatigue assessment
periodically by demographic and treatment data, Quality of life-Patient Tool, BQII,
Piper Fatigue Scale, Pain and Fatigue Knowledge Tools, and Patient Satisfaction Tool.
Patients receive usual care and undergo pain and fatigue evaluation with no algorithms
or formal education. Research nurses conduct chart audits to identify professional and
system barriers but receive no medical education, peer review, or feedback. Medical
professionals undergo assessment periodically by a Demographic Data Tool, Pain and
Fatigue Knowledge Tools, Chart Audit Tool, and Provider Satisfaction.
- Group 2 (enrolled during months 9-30): Patients and medical professionals are assessed
periodically as in group 1. Patients undergo a high-intensity Passport intervention
with algorithms based on National Comprehensive Cancer Network (NCCN) guidelines, pain
and fatigue education once weekly for 4 weeks, and follow-up reinforcement phone calls
every 2 weeks. Research nurses conduct chart audits of congruence between practice and
guidelines, tape education sessions, and receive feedback from the principal
investigator in the form of a Tape-Monitoring Checklist. Medical oncologists attend
training on the use of the algorithms, peer review pain and fatigue management audit
with feedback, and reinforce and apply content in clinical rounds.
- Group 3 (enrolled during months 34-57): Patients and medical professionals are assessed
periodically as in group 1. Patients undergo a low-intensity Passport intervention as
in group 2. Medical professionals conduct realistic implementation of the intervention
into existing systems and procedures within the cancer center, less direct education
and system intervention, and share group 2 experiences.
After completion of study intervention, patients are followed at 1 and 3 months.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |